Case Studies: Stahl's Essential Psychopharmacology: Volume 4: Children and Adolescents

by Jeffrey R. Strawn, Stephen M. Stahl

Overview

This brand-new fourth volume in Stahl's Case Studies series presents a selection of clinical case studies in child and adolescent psychopharmacology, taken from Dr. Strawn's clinics and consultations. These cases illustrate common questions that are routinely asked by Dr. Strawn's peers in consultations and which represent dilemmas in the day-to-day practice of pediatric psychopharmacology. Followings a consistent, user-friendly layout, each case features icons, tips and questions about diagnosis and management as it progresses over time, a pre-case self-assessment question, followed by the correct answers at the end of the case. Formatted in alignment with the American Board of Psychiatry and Neurology's maintenance of psychiatry speciality certification, cases address multifaceted issues in a relevant and understandable way. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way.

Product Details

ISBN-13:	9781009048965
Publisher:	Cambridge University Press
Publication date:	11/09/2023
Pages:	370
Product dimensions:	5.47(w) x 8.98(h) x 0.63(d)

About the Author

Jeffrey R. Strawn, MD is Professor of Psychiatry & Behavioral Neuroscience in the College of Medicine, University of Cincinnati, Cincinnati, Ohio.

Stephen M. Stahl, MD is Adjunct Professor of Psychiatry at the University of California, San Diego, Clinical Professor of Psychiatry and Neuroscience at the University of California, Riverside, and Honorary Visiting Senior Fellow in Psychiatry at the University of Cambridge. He is also Clinical Professor of Psychiatry in Norton College of Medicine at Upstate Medical University.

Table of Contents

Introduction; List of icons; Abbreviations; 1. The case: the salutatorian who couldn't speak: Selective Serotonin Reuptake Inhibitor (SSRI)-refractory anxiety in an adolescent; 2. The case: from anxious to activated: Selective Serotonin Reuptake Inhibitor (SSRI)-related activation; 3. The case: the girl who couldn't sleep: Posttraumatic Stress Disorder (PTSD) in a young girl; 4. The case: depressed and still depressed: Major Depressive Disorder (MDD) in an adolescent; 5. The case: a 13-year-old adolescent who feels 'amazing': Selective Serotonin Reuptake Inhibitor (SSRI)-induced mania in an adolescent; 6. The case: counting on a cure: Obsessive–Compulsive Disorder (OCD) in an adolescent; 7. The case: struggles in the second grade: Attention-Deficit Hyperactivity Disorder (ADHD) in a child; 8. The case: from prodrome to psychosis: early-onset schizophrenia; 9. The case: too much, too little, or just right? lithium dosing in an adolescent; 10. The case: tic, tic, tic: motor and vocal tics in a boy; 11. The case: how slow can you go? Selective Serotonin Reuptake Inhibitor (SSRI) withdrawal and discontinuation in an adolescent; 12. The case: the adolescent who doesn't eat: anorexia nervosa in an adolescent; 13. The case: high or higher antidepressant concentrations? cannabis-related drug interactions in an adolescent; 14. The case: the boy whose bed was always wet: nocturnal enuresis in a child; 15. The case: counting sheep and counting treatment trials: insomnia disorder in an adolescent; 16. The case: Second-Generation Antipsychotics (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with Autism Spectrum Disorder (ASD); 17. The case: the 'standard treatment' is earning a 'D': treatment-resistant schizophrenia; 18. The case: symptoms, side effects, or both? Selective Serotonin Reuptake Inhibitor (SSRI) tolerability and physical symptoms in an anxious adolescent; Index.

Editorial Reviews

‘This collection of case studies is the most comprehensive and clinically relevant that I have ever read. As a practicing Child and Adolescent Psychiatrist, I have come face to face with many of the same clinical presentations and found Dr Strawn’s review of the management thoughtful and integrative. It provides a unique framework for approaching these difficult interactions and offers a glimpse into how to combine science with the art of psychopharmacology when the evidence base is lacking. The emphasis on unique child and adolescent disorders, family dynamics and developmental pharmacology, outlines not just what the patient may need but also why. This is a must have for any Child and Adolescent Psychiatrist’s library. I will certainly use it when teaching my residents and fellows and in my own practice as well.’ Nicole M. Ballinger, DO, MPH, FAPA, Medical Staff President/Director, Child and Adolescent Psychiatry, Aurora Psychiatric Hospital, Wauwatosa, WI

‘Drs. Strawn and Stahl have really done it! The case-based teaching format and dozens of easy-to-read graphs and illustrations, walks clinicians of all levels through the complex world of pediatric psychopharmacology. Using easy-to-follow color-coded backgrounds and icons, the cases illustrate the evolution of each patient's treatment, the interplay of science and clinical wisdom, and the common pitfalls in the practice of pediatric psychopharmacology. In this era of rapidly advancing knowledge, this book provides a foundation rooted in the latest clinical pharmacology literature; it is a must-read for anyone practicing pediatric psychopharmacology.’ John T. Walkup, M.D., Margaret C. Osterman Professor of Psychiatry Chair, Pritzker Department of Psychiatry and Behavioral Health; Ann and Robert H. Lurie Children’s Hospital of Chicago; President-Elect, American Academy of Child & Adolescent Psychiatry

‘This book walks with you hand-in-hand as it describes common clinical challenges encountered while psychiatrically treating a child or adolescent. This is a must-have for novice and experienced clinicians alike, to provide clear guidance on ways to address a wide range of clinical scenarios affecting youth. In today’s complex and burdened healthcare environment, this essential psychopharmacology for child and adolescent psychiatry gives the busiest clinicians readily available tools to navigate complex scenarios with clear, sequential, and logical guidance. The clinical pearls are written in pragmatically and with adult learning principles in mind. Thank you, Drs Stahl and Strawn, for capitulating the wisdom of our field in such an accessible and engaging way.’ Manpreet Kaur Singh, M.D., M.S., Associate Professor of Psychiatry and Behavioral Sciences, Stanford University, Stanford

From the Publisher